The FDA today labeled a recall of Abbott‘s (NYSE:ABT) Heartmate 3 left ventricular assist devices over possible twisting and eventual occlusion of the outflow graft as Class I. A Class I recall is the federal watchdog’s most serious class of recall, indicating the potential for serious injury or death.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,